AIRSUPRA

AstraZeneca Pharmaceuticals LP🇺🇸 United States

FDA Page

Effective Date: Sep 18, 2025
Approval ID: e60aa9f9-5139-44df-b886-ebddc3c7eb13
Products: 1 registered
Version: 3

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use AIRSUPRA safely and effectively. See full prescribing information for AIRSUPRA. AIRSUPRA (albuterol and budesonide) inhalation aerosol, for oral inhalation useInitial U.S. Approval: 2023

Quick Stats

Total Products1

Labelers2

Label Sections31

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.